PlainPharmaWatch

CMS Open Payments · Program Year 2024

Dendreon Pharmaceuticals LLC

Dendreon Pharmaceuticals LLC reported $1,790,258.50 in payments to 10,334 physicians and teaching hospitals across 10,474 transactions.

See the rankings → How this is sourced
$1.8M
Total payments
10,474
Transactions
10,334
Recipients
−$76.4K
General Payments vs PY2023

Dendreon Pharmaceuticals LLC reported $1,790,258.50 in payments to 10,334 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #477 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $173.24 per recipient across 4 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Dendreon Pharmaceuticals LLC pairs top-quartile payment volume with an unusually diversified payment pattern across a wide recipient base.

#477
of 1,925 companies
0.0%
of all US industry payments
0.1%
paid to its single top recipient
4
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Dendreon Pharmaceuticals LLC's CMS-reported General Payments decreased by $76.4K (−10.4%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: DENDREON PHARMACEUTICALS LLCPY2023: DENDREON PHARMACEUTICALS LLCPY2024: Dendreon Pharmaceuticals LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$736.2KPY2024$659.8K
PY2023
$736,184.40
PY2024
$659,752.27

How Dendreon Pharmaceuticals LLC ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Dendreon Pharmaceuticals LLC's total vs. every reporting company

CMS Open Payments, Program Year 2024

$1,790,259 Top 25% higher than 75% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). This entry sits in this band. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Dendreon Pharmaceuticals LLC

$1,790,258.50: that is what Dendreon Pharmaceuticals LLC reported in payments to 10,334 physicians and teaching hospitals during Program Year 2024, spread across 10,474 transactions ($170.92 per transaction, $173.24 per recipient). The company sits at rank #477 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

Of the 4 general-payment categories charted below, "Food and Beverage" is the largest at $353.5K across 10,115 transactions, 19.7% of the company's reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Dendreon Pharmaceuticals LLC made 4 types of general payments. "Food and Beverage" is the largest category at $353.5K, 19.7% of the company's reported total.

How Dendreon Pharmaceuticals LLC divides its payments

How the reported total splits across payment categories

1. Food and Beverage$353.5K2. Compensation for Services…$282.9K3. Travel and Lodging$23.0K4. Education$469.00
Payment Type Amount Transactions
Food and Beverage $353.5K 10,115
Compensation for Services Other Than Consulting $282.9K 147
Travel and Lodging $23.0K 71
Education $469.00 1

Recipient Concentration in General Payments

The five largest recipient relationships account for $153,108.94 (23.2%) of $659,752.27 in this company's General Payments records across 3,497 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Dendreon Pharmaceuticals LLC

The five named recipients with the highest reported General Payments from this company

Judd Moul$45.9KJonathan Hamilton$31.3KVincent Bivins$29.3KVahan Kassabian$25.0KMahdi Taha$21.6K
  1. 1

    Judd Moul

    $45,862.75 across 28 reported transactions

  2. 2

    Jonathan Hamilton

    $31,291.91 across 56 reported transactions

  3. 3

    Vincent Bivins

    $29,344.83 across 18 reported transactions

  4. 4

    Vahan Kassabian

    $25,047.57 across 20 reported transactions

  5. 5

    Mahdi Taha

    $21,561.88 across 22 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $170.92. Average per recipient: $173.24.

Total Amount

$1,790,258.50

Avg per Transaction

$170.92

Avg per Recipient

$173.24

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Dendreon Pharmaceuticals LLC Share

0.0%

#477 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Dendreon Pharmaceuticals LLC

Merz Pharmaceuticals, LLC

$1.8M 7,100 recipients

Preceptis Medical, Inc.

$1.8M 109 recipients

A-dec, Inc.

$1.8M 7,139 recipients

Amylyx Pharmaceuticals, Inc.

$1.8M 344 recipients

Merck Healthcare KGaA

$1.8M 36 recipients

Aegis Spine, Inc.

$1.8M 38 recipients

Frequently Asked Questions

How much did Dendreon Pharmaceuticals LLC pay to physicians and hospitals in 2024? ▾
0.0% of all industry payments reported to CMS Open Payments for 2024 came from Dendreon Pharmaceuticals LLC, totaling $1,790,258.50 across 10,474 transactions to physicians and hospitals.
How many physicians received payments from Dendreon Pharmaceuticals LLC? ▾
10,334 physicians and teaching hospitals received payments from Dendreon Pharmaceuticals LLC in 2024, averaging $173.24 per recipient.
What types of payments did Dendreon Pharmaceuticals LLC make? ▾
General payments from Dendreon Pharmaceuticals LLC span 4 distinct categories, covering things like consulting, meals, and travel. The largest general-payment category was "Food and Beverage" at $353.5K, representing 19.7% of the company's reported total.
How does Dendreon Pharmaceuticals LLC rank among pharmaceutical companies? ▾
By total payment amount, Dendreon Pharmaceuticals LLC sits at #477 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Dendreon Pharmaceuticals LLC? ▾
The average transaction from Dendreon Pharmaceuticals LLC was $170.92 in 2024. The company made 10,474 total transactions to 10,334 recipients.
Where does the payment data for Dendreon Pharmaceuticals LLC come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Dendreon Pharmaceuticals LLC's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.